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The introduction of the cordycepin analog of (2’-5’)An, (2’-5’)ppp(3’dAp)n3’clA [referred to as 
(2 ‘-5 ‘)ps3 ‘dAnI, into mouse L929 cells and cultured human fibroblasts resulted in a dose-dependent 
inhibition of protein synthesis which was comparable to the inhibition observed by (2’-S’)ppp(Ap),,A 
[referred to as (2’-5’)prA.l. The inhibition of protein synthesis by (2’-5’)p33’dA, was much more 
persistent than that of the naturally occurring (2’-S’)prA, following prolonged incubation of cells. 
Furthermore, the (2’-5’)psA. was cytotoxic to mammalian cells in culture, whereas the (2’-5’)ps3’clA,, 
was not. 
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1. INTRODUCTION 
A series of oligonucleotides with the unique 
(2 ’ -5 ’ )phosphodiester linkage is synthesized by an 
interferon-induced enzyme, (2’-5’)oligoadenylate 
syuthetase [l]. These (2’ -5 ‘)psA, oligomers are 
potent inhibitors of protein synthesis in cell-free 
systems and in intact cells, probably via activation 
of a latent endonuclease (referred to as RNase L or 
RNase F), which degrades mRNA as well as rRNA 
[2]. However, (2’-5’)p&, is metabolically un- 
stable, being rapidly hydrolyzed by (2’ -5 ‘)phos- 
phodiesterase [3], which limits its use as a,biologi- 
caIly active nucleotide in intact cells. Thus, struc- 
tural modifications of (2’ -5 ‘)psA,, which would 
provide increased stability and enhanced biological 
activity have been actively investigated. 
(2 ’ -5 ’ )oligoadenylate synthetase which appears to 
possess rather a broad spectrum substrate specifici- 
ty [4]. We have reported: 
(i) The enzymatic synthesis of the cordycepin 
analog of, (2’-5’)psAn, (2’-5’)p33’dA,, 
from 3 ’ dATP, using the (2’ -5 ‘)oligoadenyl- 
ate synthetase from rabbit reticulocyte lysates; 
(ii) The effectiveness of the analog in the inhibi- 
tion of in vitro translation and in the cleavage 
of VSV mRNA by the endonuclease activated 
in the lysates; 
(iii) Its increased resistance to degradation in 
HeLa cell, L cell, and lymphoblast extracts 
[5-71. 
A number of (2 ’ -5 ’ )p,A,, analogs can be syn- 
thesized from various nucleotide triphosphates by 
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Here, we have extended the studies with 
(2’ -5 ‘)p33 ‘dA, to compare its inhibitory effect 
with that of (2’ -5 ‘)ps& on protein synthesis in 
intact mammalian cells employing the calcium 
phosphate co-precipitation technique. 
2. MATERIALS AND METHODS 
2.1. Materials 
[‘%]Methiouine (1057 Ci/mmol) was purchased 
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from New England Nuclear; minimum essential 
medium and calf serum were from GIBCO; 
(2’-5’)p3A3 and (2’-5’)p3A4 were from P.L. 
Biochemicals. (2’-5 ‘)p33 ‘dA3 and (2’-5’)p;3’- 
d& were prepared by enzymatic synthesis from 
3 ’ -dATP in rabbit reticulocyte lysates as in [5-71. 
The chemically synthesized (2’ -5 ‘)ps3 ‘dA3 and 
(2 ’ -5 ‘)ps3 ’d& were generously supplied by Dr P. 
Torrence (NIH). The structures of enzymatically 
and chemically synthesized (2’-5 ‘)p33 ’dA, have 
been reported as identical [7]. 
2.2. Cell culture 
Mouse L929 cells and normal human fibroblasts 
(GM 731) were grown in monolayer culture in 
Eagle’s minimal essential medium (MEM) sup- 
plemented with 10% calf serum. Cells were seeded 
in 24-well plates at 1.5 x 10s cells/well one day 
prior to use. 
2.3. Cell treatment with (2 ‘-5 ‘)p3An or 
(2 ‘-5 ‘1~33 ‘dA, and measurement of cellular 
protein synthesis 
The calcium phosphate co-precipitation techni- 
que was used to introduce (2’-5 ‘)psA,, and 
(2’-5’)ps3’dA, into cells as in [8]. (2’-5’)p3An or 
(2’-5’)p33’dA, were first mixed with CaClz, then 
Hepes-buffered saline (prepared from recrystalliz- 
ed Hepes) was added. The resulting solutions were 
allowed to form fine co-precipitates before being 
applied to the cell monolayers. The concentration 
of (2’-5’)p3A, or (2’-S’)p33’dA, (in 200~1) was 
10-7-10-‘o M for the first 45 min incubation at 
room temperature. An equal volume of serum-free 
medium was added to each well and incubated for 
90 min at 37°C. The liquid in each well was then 
aspirated, [35S]methionine (1057 Ci/mmol, 
2 ,&i/well) was added and incubated for 60 min. 
After 60 min, the [32S]methionine incorporated in- 
to the trichloroacetic acid-precipitable material 
was determined [8]. All assays were done in 
triplicate and data are expressed as a mean obtain- 
ed from 4 separate experiments. 
3. RESULTS AND DISCUSSION 
3.1. Inhibitory effect of (2 ‘-5 ‘)pJ ‘dA3 and 
(2 ‘-5 ‘)p33 ‘dA* on cellular protein synthesis 
Treatment of mouse L929 cells with either en- 
zymatically or chemically synthesized cordycepin 
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analogs of (2’-5’)p3An (i.e., (2’-5’)p33’dAs and 
(2 ’ -5 ‘)ps3 ’ dA4) resulted in a significant inhibi- 
tion of protein synthesis as measured by the incor- 
poration of [35S]methionine into the trichloro- 
acetic acid-precipitable material (about 70% inhi- 
bition at lo-’ M (2’-5’)ps3’dAr or (2’-5’)p33’- 
dA4) (fig.1). The inhibition by the cordycepin 
analogs was approximately the same as that ob- 
tained with the naturally occurring (2 ’ -5 ’ )psA,,. 
As in the case of (2’-5 ‘)psAn, the inhibitory effect 
of (2’ -5 ‘)p33 ’dA,, on cellular protein synthesis 
was dose-dependent. Similar results were obtained 
when these nucleotides were introduced into 
cultured human fibroblasts (GM’731) (fig.2). In 
contrast, the 5’-dephosphorylated (2’-5 ‘)An and 
(2’-5 ‘)3 ’ dA, cores did not inhibit protein syn- 
thesis in mouse L929 or human fibroblast cells (not 
I I I I I 
lo-'0 10-e 10-e 10-T 
(2'~5')p,A, or (2'~5')pd'dAn W) 
Fig.1. Inhibition of protein synthesis by (2’-S’)pjA, 
and (2’-S’)p33’dA, in mouse L929 cells. Inhibition of 
protein synthesis by (2’-5’)psAs (M), (2’-S’)p3& 
(C--O), (2’-5’)ps3’dA3 (M), and (2’-5’)p33’& 
(M) was determined in intact L929 cells using the 
calcium phosphate co-precipitation technique as in 
section 2. Control cultures were treated with calcium 
phosphate, but without oligonucleotides and the 
incorporation of [35S]methionine into control cultures 
was taken as 100%. 
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Fig.2. Inhibition of protein synthesis by (2’-5’)psA, 
and (2’-5’)p33’&4,, in cultured human fibroblasts. 
Conditions for cell treatment and protein synthesis assay 
were identical to those in fig. 1: (2’-5 ‘)p3A3 (M); 
(2’-5’)Ps& (o-o); (2’-5’)P33’d& (=-=); 
(2’-5’)p33’d& (U-0). 
shown), in agreement with [9] on HF926 cells. 
(2’ -5 ‘)p33 ‘dA4 either enzymatically or chemically 
synthesized is as good as or a better inhibitor of 
protein synthesis than is (2’ -5 ‘)p& in lysates 
from rabbit reticulocytes [7]. However, in intact 
mouse L cells (fig.l), the trimers and tetramers 
were equally potent in the inhibition of cellular 
protein synthesis, whereas the trimers appeared to 
be slightly more potent in human fibroblasts 
(fig.2). 
Using mouse L cells, we have obtained evidence 
that (2’-5’)p3An and (2’-5’)p33’dA, are actually 
taken up by the cells by calcium phosphate co- 
precipitation (in preparation). Furthermore, the 
inhibition of protein synthesis observed by 
(2’-5’)prA, and (2’-5’)p33’dAn was probably 
caused by endonuclease activation; (2’ -5 ‘)p33 ’ - 
CIA,, activates the endonuclease in lysates from rab- 
bit reticulocytes [7] and in cell-free extracts of 
mouse L cells (in preparation). These results show 
that the enzymatically and chemically synthesized 
cordycepin analogs of (2’-5’)psA, were as effec- 
tive as (2’ -5 ‘)prA,, in the inhibition of cellular 
protein synthesis, indicating that the replacement 
of the 3 ’ -hydroxyl groups on the adenylate residue 
of (2’ -5 ‘)prA, with hydrogen atoms did not 
adversely affect its ability to inhibit protein syn- 
thesis, presumably through the activation of the 
(2’ -5 ’ )A-dependent endonuclease. 
3.2. The prolonged inhibition of protein synthesis 
by (2 ‘-5 7~33 ‘dA3 and (2 ‘-5 ‘)pJ ‘dA4 
upon prolonged cell incubation 
The inhibitory effect of (2’-5 ‘)prA, on the in 
vitro or in vivo protein synthesis via endonuclease 
activation is transient, probably due to the short 
half-life of (2’ -5 ‘)psA,, [3,10]. The continued ac- 
tion of the endonuclease and the prolonged 
maintenance of protein synthesis inhibition may 
require a constant presence of (2’ -5 ‘)psA. [9]. 
Thus, an analog of (2’ -5 ‘)psA. with increased 
metabolic stability, such as (2’-5 ‘)ps3 ‘A,, [5,11], 
may maintain its ability to inhibit protein synthesis 
for a prolonged period. We compared the duration 
of the inhibition of protein synthesis and the rate 
of recovery of protein synthesis of cells in cultures 
treated with (2’-5’)p3An and (2’-5’)p33’dA, 
(fig.3). When cultures were treated with either 
(2’-5’)psA, or (2’-5’)p33’dA,, for 2.5 h, exten- 
sively washed and assayed immediately, a signifi- 
cant inhibition of protein synthesis @O-65%) was 
noted. Following the removal of the 
(2 ’ -5 ’ )nucleotides by washing and continued in- 
cubation of cells, there were marked differences in 
the recovery of protein synthesis in all cultures. It 
should be noted that shortly after the removal of 
the remaining (2’-5’)psA, or (2’-5’)p33’dA,, in 
the media, the cells began to recover from the in- 
hibition caused by (2’-5’)p3A,. On the other 
hand, the inhibition of protein synthesis by 
(2’ -5 ‘)ps3 ’ dA, became more pronounced after 
washing the cells; a maximum inhibition of protein 
synthesis was observed at 6 h post-treatment. Fur- 
thermore, the rate of protein synthesis recovery 
was much slower in cultures treated with 
(2’ -5 ‘)p33 ’dA,, than in cultures treated with 
(2’ -5 ‘)psA,. By 24 h, the cells treated with either 
(2’-5’)prAs (0) or (2’-5’)prA4 (0) had almost 
completely recovered from the inhibition, whereas 
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Fig.3. Kinetics of protein synthesis recovery after 
(2 ’ -5 ’ )paAn and (2’-5’)pp3’dA,, treatment. 
Subconfluent mouse L929 cell cultures in 24-well plates 
(1.5 x 10’ cells/well) were treated with (2’-S’)psA, or 
(2’-5’)p33 ‘dA. as in fig.1. Concentrations for all 
oligonucleotides used were 10e8 M. After incubation for 
2.5 h with calcium phosphate, all cultures were 
extensively washed, MEM containing 10% calf serum 
was added, and incubation continued. At various times 
after the addition of calcium phosphate precipitates, 
protein synthesis was measured by the labeling of cells 
with [3SS]methionine for 1 h, after which the 
incorporation of radioactivity into trichloroacetic acid- 
insoluble material was determined. Level of cellular 
protein synthesis was calculated considering the total 
radioactivity incorporated per viable cell number in the 
culture. Cell viability was determined by trypan blue 
exclusion. Control cultures treated with calcium 
phosphate alone were assayed in parallel at each time 
point shown: (2’-5’)p3As (v); (2’-S’)p& 
(C--0); (2’-5’)p33’dA3 (H); (2’-5’)pr3’dAo 
(a-0). 
about 60% and 40% inhibition of protein synthesis 
was noted in cells treated with (2 ’ -5 ‘)p33 ’dAr ( n ) 
and (2’-5 ‘)p33 ’d& ( q ), respectively. Protein 
synthesis in cultures treated with (2’-5 ‘)p3A3, 
(2’-5’)p3A4, and (2’-5’)p33’& returned to nor- 
mal by 48 h, but a noticeable inhibition (30%) was 
still observed in cultures treated with the cor- 
dycepin trimer analog, (2’-5 ‘)ps3’dA3. The in- 
hibitory effect of (2’ -5 ‘)p33 ’dA3 continued for 4 
days after the initial treatment. The observed pro- 
longed inhibitory effect of (2’-5 ‘)p33’dA3 is like- 
ly due to the increased stability of the cordycepin 
analog which can act on the (2 ’ -5 ’ )A-dependent 
endonuclease for a longer period of time and con- 
tinue to cause an extensive degradation of mRNA 
and/or rRNA. 
During the course of these experiments, a con- 
siderable cytotoxicity of (2’ -5 ‘)psA, was noted 
upon the prolonged incubation of mouse L cells. 
(2’75 ‘)psA,, resulted in about 50% cell death by 
48-96 h, while there was no apparent cytotoxic ef- 
fect of ( 2 ’ -5 ‘)p33 ’dA, (not shown). This observa- 
tion correlates well with our finding that the 
naturally occurring (2’-5’)A,, core was cytotoxic 
to human lymphocytes whereas the cordycepin 
core analog was cytostatic [12]. 
We have shown that the replacement of the 
3 ’ -hydroxyl groups of the (2 ’ -5 ’ )p3An molecule 
with hydrogen atoms does not affect the activation 
of the partially purified (2’ -5 ’ )A-dependent en- 
donuclease, hydrolysis of VSV mRNA and inhibi- 
tion of protein synthesis in lysates from rabbit 
reticulocytes [7]. The cordycepin analog also in- 
hibits protein synthesis in L929 cells and normal 
human fibroblasts. These in vivo findings verify 
our earlier in vitro studies that the cordycepin 
analogs of (2’-5’)A inhibit protein synthesis 
[5-71. It is of interest that neither the cordycepin 
trimer triphosphate nor the tetramer triphosphate 
analogs were inhibitors of translation in mouse L- 
cell free extracts programmed with encephalomyo- 
carditis virus [13]. 
Since our original report on the enzymatic syn- 
thesis, increased metabolic stability and inhibition 
of protein synthesis by the cordycepin analog of 
(2’ -5 ‘)psA, [14], studies have expanded in which 
modification of the 2’ -terminus of the 
(2 ’ -5 ‘)p3A, molecule results in (2 ’ -5 ‘)p3An 
analogs which also have increased metabolic 
stabilities, inhibit protein synthesis and inhibit 
methylation of the S’cap of mRNA 
[9,11,13,15-171. The eventual goal of these studies 
would be the design of an analog of the 
(2’-5’)p3A, molecule that could replace the 
metabolically unstable (2 ’ -5 ’ )prA,, and be 
suitable for use in the treatment of virus diseases or 
cancer. 
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